|
Index of reports
> Cases resulting in a serious event (461)
> Cases with Weight Decreased (41)
Below is the selection of adverse event reports related to Topamax (Topiramate) that includes cases resulting in a serious event where reactions include weight decreased.
Reports 1 - 25 of 41 Next >>
Adverse event in female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-10-11
Patient: female, weighing 58.1 kg (127.7 pounds)
Adverse reactions / side effects: Weight Decreased, Food Aversion, Speech Disorder, Heat Stroke, Disorientation, Somnolence, Amnesia
Suspect drug(s):
Topamax (Topiramate)
Other drugs received by patient: Antidepressant; Premarin; Progesterone; Glucosamine; Multi-Vitamin
Adverse event in 57 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-10-08
Patient: 57 year old female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Weight Decreased, Personality Change, Blood Urine Present, Partner Stress, Musculoskeletal Pain, Mental Status Changes, Periarthritis, Aggression, Tremor, Dysgeusia, Nephrolithiasis, Mood Altered, Anorexia, Depression
Suspect drug(s):
Topamax (Topiramate)
Other drugs received by patient: Synthroid; Unknown Medication
Adverse event in female receiving Topamax (Topiramate)
Reported by a health professional (non-physician/pharmacist) from Ireland on 2007-10-05
Patient: female, weighing 54.0 kg (118.8 pounds)
Adverse reactions / side effects: Weight Decreased, Anorexia Nervosa, Decreased Appetite
Suspect drug(s):
Topamax
Indication: Convulsion
Topamax
Indication: Migraine
Adverse event in receiving Topamax (Topiramate)
Reported by a physician from United States on 2007-07-19
Patient:
Adverse reactions / side effects: Weight Decreased, Renal Cyst
Suspect drug(s):
Topamax (Topiramate)
Adverse event in female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-07-13
Patient: female, weighing 45.4 kg (99.8 pounds)
Adverse reactions / side effects: Weight Decreased, Loss of Consciousness
Suspect drug(s):
Topamax (Topiramate)
Adverse event in 36 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-07-11
Patient: 36 year old female, weighing 76.2 kg (167.6 pounds)
Adverse reactions / side effects: Weight Decreased, Vomiting, Nausea, Injection Site Haemorrhage, Injection Site Pain, Injection Site Bruising, Gastric Disorder, Fatigue, Diarrhoea, Enteritis, Decreased Appetite, Influenza Like Illness
Suspect drug(s):
Betaseron
Dosage: 2 miu, every 2d
Indication: Relapsing-Remitting Multiple Sclerosis
Start date: 2007-05-25
End date: 2007-01-01
Betaseron
Dosage: 6 miu, every 2d
Start date: 2007-01-01
Topamax
Dosage: 100 mg/d, unk
Indication: Migraine
Other drugs received by patient: Zoloft; Zocor; Trazodone HCL
Adverse event in 29 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-07-06
Patient: 29 year old female, weighing 65.8 kg (144.7 pounds)
Adverse reactions / side effects: Weight Decreased, Nausea, Pain, Tachycardia, Arrhythmia, Thyroid Cyst, Hyperventilation, Thyroiditis
Adverse event resulted in: hospitalization
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Topamax
Dosage: 25mg - 100mg daily
Administration route: Oral
Indication: Drug Therapy
Steroids
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Seroquel; Lithium Carbonate
Adverse event in female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-06-29
Patient: female, weighing 72.6 kg (159.7 pounds)
Adverse reactions / side effects: Electroencephalogram Abnormal, Funnel Chest Acquired, Weight Decreased, Diarrhoea, Insomnia
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Indication: Migraine Prophylaxis
Other drugs received by patient: Seroquel; Magnesium Sulfate; Diflunisal; Premphase 14 / 14; Flonase; Lorazepam; Imitrex
Adverse event in male receiving Topamax (Topiramate)
Reported by a pharmacist from United States on 2007-06-28
Patient: male, weighing 69.9 kg (153.7 pounds)
Adverse reactions / side effects: Weight Decreased, Abdominal Pain, Nausea, Fear, Condition Aggravated, Dyspepsia, Diarrhoea, Mood Altered, Anorexia, Depression, Temperature Intolerance, Hyperchloraemia
Suspect drug(s):
Topamax (Topiramate)
Other drugs received by patient: Prevacid; Fluoxetine; Promethazine
Adverse event in 15 year old female receiving Topamax (Topiramate)
Reported by a pharmacist from United States on 2007-06-20
Patient: 15 year old female
Adverse reactions / side effects: Weight Decreased, Educational Problem, Abnormal Behaviour, Drug Dispensing Error, Somnolence
Suspect drug(s):
Topamax
Administration route: Oral
Indication: Complex Partial Seizures
Lamictal
Administration route: Oral
Indication: Complex Partial Seizures
Adverse event in 15 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-06-13
Patient: 15 year old female
Adverse reactions / side effects: Weight Decreased, Educational Problem, Abnormal Behaviour, Drug Dispensing Error, Somnolence, Convulsion
Suspect drug(s):
Lamictal
Dosage: 25mg unknown
Topamax
Dosage: 25mg unknown
Adverse event in female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-05-25
Patient: female
Adverse reactions / side effects: Weight Decreased, Blood Potassium Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Topamax
Indication: Drug Therapy
Provigil
Indication: Narcolepsy
Other drugs received by patient: Synthroid; Lipitor; Relpax; Klor-CON; Magoxide; Multi-Vitamin
Adverse event in 34 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-05-22
Patient: 34 year old female, weighing 45.4 kg (99.8 pounds)
Adverse reactions / side effects: Weight Decreased, Drug Effect Increased, Visual Disturbance, Memory Impairment, Convulsion, Loss of Consciousness
Suspect drug(s):
Topamax (Topiramate)
Adverse event in 57 year old male receiving Topamax (Topiramate)
Reported by a individual with unspecified qualification from United States on 2007-05-18
Patient: 57 year old male, weighing 90.7 kg (199.6 pounds)
Adverse reactions / side effects: Bedridden, Weight Decreased, Wheelchair User, Abasia, Parkinsonism, Hyperhidrosis, Erythema, Walking AID User, Dizziness, Dysgraphia, Motion Sickness, Vomiting, Blood Homocysteine Increased, Loss of Control of Legs, Nausea, Ill-Defined Disorder, Dysarthria, Diarrhoea, Activities of Daily Living Impaired, NO Therapeutic Response, Disturbance in Attention, Gait Disturbance
Adverse event resulted in: disablity
Suspect drug(s):
Topamax (Topiramate)
Adverse event in 44 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from Canada on 2007-05-11
Patient: 44 year old female, weighing 42.6 kg (93.8 pounds)
Adverse reactions / side effects: Choking Sensation, Weight Decreased, Nasopharyngitis, Therapeutic Response Unexpected, Herpes Zoster, Pharyngeal Oedema, Skin Discolouration, Chest Pain, Dizziness, Palmar Erythema, Gastrooesophageal Reflux Disease, Muscle Spasms, RIB Fracture, Swelling Face, Chest Discomfort, Dyspnoea, Pain in Extremity, Muscular Weakness, Hypoaesthesia, Swollen Tongue, Musculoskeletal Chest Pain, Convulsion, Tremor, Anxiety, Burning Sensation, Throat Irritation, Sensory Disturbance, Depressed Level of Consciousness, Cardiovascular Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Topamax
Topamax
Indication: Pain Management
Ciprofloxacin
Indication: Drug USE FOR Unknown Indication
Forteo
Indication: Osteoporosis
Other drugs received by patient: Demerol; Tylenol; Ogen; Calcium Chloride; Vitamin D; Vitamin B-12; Miacalcin
Adverse event in 54 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-05-01
Patient: 54 year old female, weighing 93.4 kg (205.6 pounds)
Adverse reactions / side effects: Weight Decreased, Fatigue, Insomnia, Therapeutic Response Unexpected, Asthenia, Cerebrovascular Accident, Somnolence
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Indication: Headache
Other drugs received by patient: Prozac
Adverse event in 28 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-05-01
Patient: 28 year old female, weighing 84.4 kg (185.6 pounds)
Adverse reactions / side effects: Weight Decreased, Confusional State, Personality Change, Obsessive-Compulsive Disorder, Depersonalisation, Abnormal Behaviour, Mania, Apathy, Affective Disorder, Affect Lability, Anorexia, Disturbance in Attention, Memory Impairment, Nervousness
Suspect drug(s):
Topamax (Topiramate)
Other drugs received by patient: Wellbutrin
Adverse event in 53 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from Brazil on 2007-04-19
Patient: 53 year old female, weighing 49.0 kg (107.8 pounds)
Adverse reactions / side effects: Weight Decreased, Anorexia, Chest Pain, Tachycardia, Asthenia
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Indication: Depression
Other drugs received by patient: Rivotril; Synthroid
Adverse event in 59 year old male receiving Topamax (Topiramate)
Reported by a individual with unspecified qualification from United States on 2007-04-19
Patient: 59 year old male, weighing 81.7 kg (179.6 pounds)
Adverse reactions / side effects: Weight Decreased, Fatigue, Malaise, Anorexia, Hypoglycaemia, Convulsion
Suspect drug(s):
Starlix
Dosage: 120 mg, tid
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2006-06-02
End date: 2006-10-05
Starlix
Dosage: 120 mg, bid
Administration route: Oral
Start date: 2006-10-06
End date: 2006-12-22
Depakote
Indication: Convulsion
Lantus
Dosage: 14 u, qd
Indication: Diabetes Mellitus
Start date: 2006-04-01
Lantus
Dosage: 10 u, qd
Lantus
Dosage: 8 u, qd
Lantus
Dosage: 6 u, qd
Administration route: Oral
Start date: 2006-04-01
Topamax
Dosage: 400 mg, qd
Start date: 2006-09-01
Other drugs received by patient: Januvia; Tricor; Trileptal; ^homocore^; ^lisciol^; Zetia
Adverse event in 30 year old male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United Kingdom on 2007-04-13
Patient: 30 year old male
Adverse reactions / side effects: Weight Decreased, Sleep Disorder, Memory Impairment
Suspect drug(s):
Topamax (Topiramate)
Other drugs received by patient: Clonazepam
Adverse event in female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-04-13
Patient: female, weighing 71.7 kg (157.7 pounds)
Adverse reactions / side effects: Weight Decreased, Somnolence, Loss of Consciousness, Dysarthria, Dehydration, Feeling Hot, Vertigo, Blood Pressure Decreased
Suspect drug(s):
Topamax
Administration route: Oral
Indication: Muscle Spasms
Topamax
Administration route: Oral
Indication: Multiple Sclerosis
Other drugs received by patient: Rebif
Adverse event in female receiving Topamax (Topiramate)
Reported by a physician from United States on 2007-04-10
Patient: female
Adverse reactions / side effects: Weight Decreased, Diarrhoea, Hyperammonaemia
Suspect drug(s):
Topamax (Topiramate)
Other drugs received by patient: Lamictal
Adverse event in female receiving Topamax (Topiramate)
Reported by a physician from Australia on 2007-04-09
Patient: female
Adverse reactions / side effects: Weight Decreased, Impaired Gastric Emptying, Blood Prolactin Abnormal
Suspect drug(s):
Topamax
Administration route: Oral
Indication: Depressed Level of Consciousness
Topamax
Administration route: Oral
Indication: Migraine Prophylaxis
Motilium
Administration route: Oral
Indication: Impaired Gastric Emptying
Adverse event in female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-04-05
Patient: female, weighing 63.5 kg (139.7 pounds)
Adverse reactions / side effects: Weight Decreased, Dysphagia, Dyspnoea, Abasia, Aphasia, Muscle Rigidity, Incontinence, Choking, Hallucination
Adverse event resulted in: hospitalization
Suspect drug(s):
Risperdal
Risperdal
Indication: Schizophrenia
Topamax
Indication: Drug Therapy
Topamax
Indication: Weight Decreased
Other drugs received by patient: Ativan; Artane; Birth Control Pill; Imodium
Adverse event in male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-03-30
Patient: male, weighing 149.7 kg (329.3 pounds)
Adverse reactions / side effects: Weight Decreased, Lung Neoplasm Malignant, Cough
Adverse event resulted in: death
Suspect drug(s):
Topamax (Topiramate)
Other drugs received by patient: Prevacid; Protonix; Lisinopril
Page 1 Next >>
|
